Major depressive disorder with seasonal patterns, also known as seasonal affective disorder, causes symptoms similar to ...

Circuits in the brain that are crucially involved in implementing decisions by directing between perseverance, exploration ...

Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on earnings, a study approval ...

Neurocrine Biosciences (NasdaqGS:NBIX) announced the initiation of a Phase 1 clinical study for the compound NBI-1140675, a new VMAT2 inhibitor. This development could influence investor sentiment, ...

Genetic predisposition to traits such as depressive affect, neuroticism and insomnia appeared significantly associated with ...

A new study identifies four clusters of spontaneous thought that allow our minds to run free and stay positive or get stuck in negative, loop-like thinking.

Mind Medicine (MindMed) Inc. ( NASDAQ: MNMD) Q4 2024 Earnings Conference Call March 6, 2025 8:00 AM ET Stephanie Fagan - Chief Corporate Affairs Officer Rob Barrow - CEO Dan Karlin - CMO ...

Sleep issues can stem from various causes, but transcranial magnetic stimulation therapy offers a promising non-pharmacological option for restorative sleep.

Shares of Alto Neuroscience, Inc. (NYSE:ANRO – Get Free Report) traded up 8.8% on Wednesday . The company traded as high as $3.56 and last traded at $3.39. 973,685 shares were traded during trading, ...

Neumora Therapeutics (NASDAQ:NMRA – Get Free Report)‘s stock had its “sector perform” rating reaffirmed by investment ...

Axsome Therapeutics AXSM announced that it has entered into a settlement agreement with Hikma Pharmaceuticals related to ...